Squamous Cell Carcinoma of Unknown Primary
Associated Genetic Biomarkers
NCI Definition: A squamous cell carcinoma which has metastasized to another anatomic site and the original site of growth has not been identified. 
There are 3 clinical trials for squamous cell carcinoma of unknown primary, of which 3 are open and 0 are completed or closed. Of the trials that contain squamous cell carcinoma of unknown primary as an inclusion criterion, 3 are phase 2 (3 open).
Isa101b, avelumab, and cemiplimab are the most common interventions in squamous cell carcinoma of unknown primary clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.